TargetRx Announces Management Transition

Craig Scott Assumes Chief Executive Officer Position
HORSHAM, Pa.--(Business Wire)--TargetRx Inc. today announced that Craig H. Scott has been
appointed to the role of president and chief executive officer, and he
will join the board of directors, effective immediately. Scott assumes
the role from Michael J. Luby, company founder who will remain a
full-time employee of the company and a member of the board of
directors.

"We are pleased to have established TargetRx as the only company
to enhance pharmaceutical sales force and marketing effectiveness by
helping clients to measure, manage and improve performance against the
key drivers of physician prescribing behavior. I am confident Craig's
proven leadership abilities will propel the company into its next
phase of growth," said Luby. "I believe his wealth of experience in
the pharmaceutical services industry, combined with his energy and
vision, will be great assets to the future success of TargetRx."

Scott joins TargetRx with a broad range of pharmaceutical
marketing, sales and general management experience on both the client
and service sides, and in both Fortune 100 and entrepreneurial
start-up organizations. Prior to joining TargetRx, he was president of
the Catalina Health Resource division of Catalina Marketing
Corporation from 2004 until the leveraged buyout of the company in
November 2007. During his tenure, he dramatically increased revenues
and profits and led the transformation of Catalina Health Resource
into the leading provider of direct-to-patient communication services
in pharmacies nationwide.

Scott joined Catalina after nine years with Nelson Communications,
where he established several new healthcare marketing ventures,
leading them from concept to implementation and commercial success.
Prior to his work at Nelson Communications, Scott spent 13 years with
Johnson & Johnson, where he held a variety of marketing and management
positions. Most notably at J&J, Scott served as vice president of
marketing as well as a management board member for Vistakon, the J&J
affiliate that launched ACUVUE(R), the first disposable and
best-selling contact lens in the world.

"I am enthused by TargetRx's proprietary predictive modeling
database," said Scott. "With a comprehensive understanding of
physician attitudes about products, promotion, payors and patients, we
can offer pharmaceutical companies robust information that will
fundamentally improve the effectiveness of their sales and marketing
efforts. At this critical time for the industry, TargetRx will
continue to provide clients with superior tools that will enable them
to increase market share and improve the bottom line."

Scott received his bachelor's degree in semiotics from Brown
University and his master's degree in business administration from The
Wharton School of Business at the University of Pennsylvania. He
currently resides in Doylestown, Pennsylvania with his wife and their
two children.

About TargetRx

TargetRx helps pharmaceutical companies create competitive
advantage and shareholder value through unparalleled insights into the
drivers of physician prescribing behavior. TargetRx products and
services help pharmaceutical clients to deploy more effective and
efficient sales and marketing programs. TargetRx employs a unique
database approach to capturing physician attitudes and translating the
findings into highly actionable insight for its clients. TargetRx has
developed a highly predictive, large-scale normative database of
physician attitudes that it uses in combination with its patented
proprietary analytic methods to provide pharmaceutical companies with
powerful "leading indicators" of performance. These insights provide
companies with benchmarks for how they are currently performing, rich
diagnostics that identify immediate ways to improve, and powerful
forecasts that accurately predict future performance. TargetRx works
with the majority of the top 30 pharmaceutical companies in the U.S.
For further information, visit www.targetrx.com or call 215-444-8900.

Lois Paul & Partners
Susan Lombardo, 781-782-5767
susan_lombardo@lpp.com

Copyright Business Wire 2008